Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Daniotti

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Alimentary Pharmacology & Therapeutics|June 1, 1989
Effects of cimetropium bromide on gastrointestinal transit time in patients with irritable bowel syndromeS Passaretti, M Guslandi, B P Imbimbo, et al.
Hepato-Gastroenterology|August 1, 1987
Luminal bicarbonate outflow in chronic antral erosions is suppressed by pirenzepineM Guslandi, E Masci, E Ballarin, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Urinary excretion of cimetropium bromide after multiple oral dosesB P Imbimbo, A Piperno, G Fiorelli, et al.
Scandinavian Journal of Gastroenterology|January 1, 1981
Inhibition by pirenzepine of nocturnal gastric acid secretion in duodenal ulcer patientsR Corinaldesi, M Miglioli, S Daniotti, et al.
Journal of Pharmaceutical Sciences|July 1, 1986
Discontinuous oral absorption of cimetropium bromide, a new antispasmodic drugB P Imbimbo, S Daniotti, A Vidi, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1987
Cimetropium bromide, a new antispasmodic agent, has no hemolytic effects in humansA Piperno, F Muzio, B P Imbimbo, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1982
Cytoprotection by PGE2, atropine, pirenzepine and vagotomy in ratsV Rovati, D Foschi, F Ferrante, et al.
The American Journal of Gastroenterology|November 1, 1988
Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndromeV Centonze, B P Imbimbo, F Campanozzi, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Action of mifentidine on the secretory response to sham feeding and pentagastrin and on serum gastrin in duodenal ulcer patientsG Bianchi Porro, M Lazzaroni, B P Imbimbo, et al.
Digestive Diseases and Sciences|February 1, 1985
Identification of muscarinic receptor subtype mediating colonic response to eatingF Narducci, G Bassotti, S Daniotti, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Alimentary Pharmacology & Therapeutics|June 1, 1989
Effects of cimetropium bromide on gastrointestinal transit time in patients with irritable bowel syndromeS Passaretti, M Guslandi, B P Imbimbo, et al.
Hepato-Gastroenterology|August 1, 1987
Luminal bicarbonate outflow in chronic antral erosions is suppressed by pirenzepineM Guslandi, E Masci, E Ballarin, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Urinary excretion of cimetropium bromide after multiple oral dosesB P Imbimbo, A Piperno, G Fiorelli, et al.
Scandinavian Journal of Gastroenterology|January 1, 1981
Inhibition by pirenzepine of nocturnal gastric acid secretion in duodenal ulcer patientsR Corinaldesi, M Miglioli, S Daniotti, et al.
Journal of Pharmaceutical Sciences|July 1, 1986
Discontinuous oral absorption of cimetropium bromide, a new antispasmodic drugB P Imbimbo, S Daniotti, A Vidi, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1987
Cimetropium bromide, a new antispasmodic agent, has no hemolytic effects in humansA Piperno, F Muzio, B P Imbimbo, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1982
Cytoprotection by PGE2, atropine, pirenzepine and vagotomy in ratsV Rovati, D Foschi, F Ferrante, et al.
The American Journal of Gastroenterology|November 1, 1988
Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndromeV Centonze, B P Imbimbo, F Campanozzi, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Action of mifentidine on the secretory response to sham feeding and pentagastrin and on serum gastrin in duodenal ulcer patientsG Bianchi Porro, M Lazzaroni, B P Imbimbo, et al.
Digestive Diseases and Sciences|February 1, 1985
Identification of muscarinic receptor subtype mediating colonic response to eatingF Narducci, G Bassotti, S Daniotti, et al.
Pageof 4